Medicine
Noxafil 100 mg tablet
Noxafil 100 mg tablet is a prescription medicine containing Posaconazole for oral use, marketed by Merck Sharp & Dohme, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians. It ships in a temperature-controlled cold chain.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Cold chain
Store Noxafil injection vial refrigerated at 2 to 8°C (36 to 46°F). DO NOT…
Key facts
- Active ingredient (INN)
- Posaconazole
- Brand
- Noxafil
- Strength
- 100 mg
- Dosage form
- Tablet
- Route
- Oral
- Packs
- 60 tablets
- Marketing authorisation holder
- Merck Sharp & Dohme
- Manufacturer
- Merck Sharp & Dohme
- Origin register
- US FDA, United States
- Storage
- Store Noxafil injection vial refrigerated at 2 to 8°C (36 to 46°F). DO NOT FREEZE. Noxafil Delayed-Release Tablets Store at 20 to 25°C (68 to 77°F), excursions permitted to 15 to 30°C (59 to 86°F). Noxafil Oral Suspension Store at 25°C (77°F), excursions permitted to 15 to 30°C (59 to 86°F).
- Cold chain
- Yes, shipped temperature controlled
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- J02AC04 Posaconazole
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 25 November 2013
- Identifiers
- RxCUI 665019, 665022, 1482908 +5DailyMed set ID b073b082-7b57-4423-8c06-4fd4263d6f84NDC 0085-4324Application NDA205053
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 60 tablet, coated in 1 bottle | 0085-4324-02 | Merck Sharp & Dohme | 25 November 2013 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Posaconazole 100 mg tablet.
Other strengths and forms of Posaconazole
Clinical summary
Posaconazole is an azole antifungal indicated as follows, among other approved uses. It is available as delayed-release tablets, injection and tablets for oral and intravenous use. MedsAcross supplies Posaconazole for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about PosaconazoleFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- POSACONAZOLE prescribing information (Endo) · U.S. National Library of Medicine, DailyMed
- Noxafil: European public assessment report (EPAR) · European Medicines Agency
- Posaconazole Accord: European public assessment report (EPAR) · European Medicines Agency
Need Noxafil 100 mg tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.